This was from the October 6th press release.

Quote:

---

"...efficacy, manufacturing, and agreement on trial design, all of which we have come to agreement with the regulators on," said Thomas Ichim, Ph.D.,

---

He goes on to say

Quote:

---

"The current discussions with the FDA are about which test system is most reliable for demonstrating safety

---

I believe an update about HemaXellerate is very very soon.